These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 18551139)
1. Intravitreal pegaptanib in severe proliferative diabetic retinopathy leading to the progression of tractional retinal detachment. Krishnan R; Goverdhan S; Lochhead J Eye (Lond); 2009 May; 23(5):1238-9. PubMed ID: 18551139 [No Abstract] [Full Text] [Related]
2. Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy. Arevalo JF; Maia M; Flynn HW; Saravia M; Avery RL; Wu L; Eid Farah M; Pieramici DJ; Berrocal MH; Sanchez JG Br J Ophthalmol; 2008 Feb; 92(2):213-6. PubMed ID: 17965108 [TBL] [Abstract][Full Text] [Related]
3. Progression of diabetic tractional retinal detachment following single injection of intravitreal Avastin. Tranos P; Gemenetzi M; Papandroudis A; Chrisafis C; Papadakos D Eye (Lond); 2008 Jun; 22(6):862. PubMed ID: 18007674 [No Abstract] [Full Text] [Related]
4. Intravitreal injection of pegaptanib sodium for proliferative diabetic retinopathy. González VH; Giuliari GP; Banda RM; Guel DA Br J Ophthalmol; 2009 Nov; 93(11):1474-8. PubMed ID: 19692371 [TBL] [Abstract][Full Text] [Related]
5. Retinal detachment with macular hole following intravitreal bevacizumab in patient with severe proliferative diabetic retinopathy. Mitamura Y; Ogata K; Oshitari T; Asaumi N; Yamamoto S Br J Ophthalmol; 2008 May; 92(5):717-8. PubMed ID: 18441183 [No Abstract] [Full Text] [Related]
6. Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals. Adamis AP; Altaweel M; Bressler NM; Cunningham ET; Davis MD; Goldbaum M; Gonzales C; Guyer DR; Barrett K; Patel M; Ophthalmology; 2006 Jan; 113(1):23-8. PubMed ID: 16343627 [TBL] [Abstract][Full Text] [Related]
7. [One year outcomes of pars plana vitrectomy in proliferative diabetic retinopathy]. Tadera M; Kawamura H; Fujikawa M; Kakinoki M; Sawada T; Saishin Y; Ohji M Nippon Ganka Gakkai Zasshi; 2014 Jun; 118(6):502-7. PubMed ID: 25016792 [TBL] [Abstract][Full Text] [Related]
8. Reducing the incidence of early postoperative vitreous haemorrhage by preoperative intravitreal bevacizumab in vitrectomy for diabetic tractional retinal detachment. Yeung L; Liu L; Wu WC; Kuo YH; Chao AN; Chen KJ; Yang KJ; Chen TL; Lai CC Acta Ophthalmol; 2010 Sep; 88(6):635-40. PubMed ID: 19432872 [TBL] [Abstract][Full Text] [Related]
9. Perfluoro-N-octane (PFO) in the repair of complicated retinal detachments due to severe proliferative diabetic retinopathy. Maturi RK; Merrill PT; Lomeo MD; Diaz-Rohena R; Khan M; Lambert HM Ophthalmic Surg Lasers; 1999; 30(9):715-20. PubMed ID: 10574492 [TBL] [Abstract][Full Text] [Related]
10. Long-term results of vitrectomy without endotamponade in proliferative diabetic retinopathy with tractional retinal detachment. Tao Y; Jiang YR; Li XX; Gao L; Jonas JB Retina; 2010 Mar; 30(3):447-51. PubMed ID: 20216292 [TBL] [Abstract][Full Text] [Related]
12. Intra-silicone oil injection of methotrexate at the end of vitrectomy for advanced proliferative diabetic retinopathy. Ghasemi Falavarjani K; Modarres M; Hadavandkhani A; Karimi Moghaddam A Eye (Lond); 2015 Sep; 29(9):1199-203. PubMed ID: 26160528 [TBL] [Abstract][Full Text] [Related]
13. Intravitreal triamcinolone for treatment of complicated proliferative diabetic retinopathy and proliferative vitreoretinopathy. Munir WM; Pulido JS; Sharma MC; Buerk BM Can J Ophthalmol; 2005 Oct; 40(5):598-604. PubMed ID: 16391623 [TBL] [Abstract][Full Text] [Related]
17. Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment. Oshima Y; Shima C; Wakabayashi T; Kusaka S; Shiraga F; Ohji M; Tano Y Ophthalmology; 2009 May; 116(5):927-38. PubMed ID: 19269033 [TBL] [Abstract][Full Text] [Related]
18. A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. Cunningham ET; Adamis AP; Altaweel M; Aiello LP; Bressler NM; D'Amico DJ; Goldbaum M; Guyer DR; Katz B; Patel M; Schwartz SD; Ophthalmology; 2005 Oct; 112(10):1747-57. PubMed ID: 16154196 [TBL] [Abstract][Full Text] [Related]
19. Avastin as an adjunct to vitrectomy in the management of severe proliferative diabetic retinopathy: a prospective case series. Yeoh J; Williams C; Allen P; Buttery R; Chiu D; Clark B; Essex R; McCombe M; Qureshi S; Campbell WG Clin Exp Ophthalmol; 2008 Jul; 36(5):449-54. PubMed ID: 18942219 [TBL] [Abstract][Full Text] [Related]
20. [Evaluation of the usefulness of vitrectomy in the treatment of proliferative diabetic retinopathy]. Szymańska M Klin Oczna; 1992; 94(7-8):197-8. PubMed ID: 1300399 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]